Intelligence · Clinical Development
Pipeline search results
Programs matching “ophthalmic” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 35 pipeline programs matching "ophthalmic" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients
AstraZeneca AB
Breast Cancer
1 trial -
Bimatoprost Ophthalmic Solution, 0.01%
Amneal Pharma Europe Ltd
Open-angle Glaucoma
1 trial -
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution
LENZ Therapeutics
Presbyopia
1 trial -
TP-03 (Lotilaner Ophthalmic Solution), 0.25%
Tarsus Pharmaceuticals
Healthy
1 trial -
USB005 (aclerastide) Ophthalmic Solution
United Therapeutics Europe Ltd
Healthy Volunteers
1 trial -
0.1% bromfenac
Zhongshan Ophthalmic Center, Sun Yat-sen University
Pterygium
1 trial -
Aflibercept Ophthalmic
Regeneron UK Limited
Wet Macular Degeneration
1 trial -
Lotilaner ophthalmic solution, 0.25%
Tarsus Pharmaceuticals
Demodex Blepharitis
1 trial -
Rebamipide 2% ophthalmic solution
Samsung Bioepis NL B.V.
Dry Eye Disease (DED)
1 trial -
0.1% bromfenac ophthalmic solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Routine IOP-lowering medications
Zhongshan Ophthalmic Center, Sun Yat-sen University
Open Angle Glaucoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.